|
HY-141220-500mg
|
MedChemexpress LLC
|
m-PEG12-OH [CAS 2050595-03-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W018174-1g
|
MedChemexpress LLC
|
m-PEG3-Amine [CAS 74654-07-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W018174-100mg
|
MedChemexpress LLC
|
m-PEG3-Amine [CAS 74654-07-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W018174-500mg
|
MedChemexpress LLC
|
m-PEG3-Amine [CAS 74654-07-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W018174-1mL
|
MedChemexpress LLC
|
m-PEG3-Amine [CAS 74654-07-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-W067509-100mg
|
MedChemexpress LLC
|
m-PEG3-CH2CH2COOH [CAS 67319-28-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W067509-250mg
|
MedChemexpress LLC
|
m-PEG3-CH2CH2COOH [CAS 67319-28-2]
|
|
Cancer-programmed cell death
|
|
|
HY-141395-100mg
|
MedChemexpress LLC
|
m-PEG4-Boc [CAS 883554-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-141395-250mg
|
MedChemexpress LLC
|
m-PEG4-Boc [CAS 883554-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-141395-50mg
|
MedChemexpress LLC
|
m-PEG4-Boc [CAS 883554-11-8]
|
|
Cancer-programmed cell death
|
|
|
HY-130457-100mg
|
MedChemexpress LLC
|
m-PEG4-Ms [CAS 130955-37-2]
|
|
Cancer-programmed cell death
|
|
|
HY-130457-250mg
|
MedChemexpress LLC
|
m-PEG4-Ms [CAS 130955-37-2]
|
|
Cancer-programmed cell death
|
|
|
HY-130457-50mg
|
MedChemexpress LLC
|
m-PEG4-Ms [CAS 130955-37-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W035376-100mg
|
MedChemexpress LLC
|
m-PEG6-CH2CH2CHO [CAS 1058691-77-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W035376-250mg
|
MedChemexpress LLC
|
m-PEG6-CH2CH2CHO [CAS 1058691-77-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W035376-50mg
|
MedChemexpress LLC
|
m-PEG6-CH2CH2CHO [CAS 1058691-77-2]
|
|
Cancer-programmed cell death
|
|
|
H2A228-1
|
Virusys Corporation
|
HSV-2, Chicken Polyclonal Antibody
|
Virus
|
ELISA, IF, WB
|
|
